+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Molecular Diagnostic Market and Testing

  • ID: 3068112
  • Report
  • February 2014
  • Region: Global
  • 122 Pages
  • Insight Pharma Reports
This report focuses on market background of the areas that are covered, including lung, breast, thyroid and blood cancers (specifically leukemia and lymphoma), as well as pre-conception genetic information and prenatal diagnostics.

Included in this Report:

- Cancer diagnostics companies interviewed include: GeneCentric, Veracyte, Adaptive Biotechnologies
- Genetic and prenatal diagnostics research companies including GenePeeks and Verinata Health
- Comprehensive coverage of survey results (n=123) from the various companies and researchers working in molecular diagnostics.
- A company directory which was created for this report. This includes several seasoned and emerging companies, their areas of focus, and the status of their technologies
Note: Product cover images may vary from those shown
Executive Summary

PART I: Introduction and Market Background

CHAPTER 1: The Focus of This Report

CHAPTER 2: Market Trends and Adaptability

Lung cancer diagnostics market growth
Breast cancer diagnostics market growth
Thyroid cancer diagnostics market growth
Blood cancer diagnostics market growth
Prenatal diagnostics market growth

PART II: Cancer Diagnostics

CHAPTER 3: Lung Cancer

Types of lung cancer
Risk factors
Incidence
Symptoms and early detection
Targeted therapies

CHAPTER 4: Breast Cancer

Types of breast cancer
Risk factors
Incidence
Symptoms and early detection
Treatments for breast cancer

CHAPTER 5: GeneCentric

Company background
Lung Subtype Platform (LSP)
Hypoxia Signature Platform
GeneCentric outlook
Interview with Myla Lai-Goldman
Company background
Platforms
Future outlook

CHAPTER 6: Thyroid Cancer

Types
Risk
Symptoms and early detection
Therapeutic options

CHAPTER 7: Veracyte

Company background
Afirma Thyroid FNA Analysis
Validation
Competitive advantage
Future growth plans
Interview with Bonnie Anderson
Company background
Afirma Thyroid FNA Analysis
Competitive advantage
Challenges encountered
Future improvements

CHAPTER 8: Blood-Based Cancers

Leukemia
Types
Risk factors, symptoms and early detection
Therapeutic options
Lymphoma
Types
Classic Hodgkin disease
Nodular lymphocyte predominant Hodgkin disease
Non-Hodgkin lymphoma
Risk factors
Symptoms and therapeutic options

CHAPTER 9: Adaptive Biotechnologies Corporation

Company background
ClonoSEQ
Validation
Areas of improvement
Competitive advantage
Future endeavors
Interview with Chad Robins
Company background
ClonoSEQ
Areas of improvement
Challenges encountered
Competitive advantage
Future endeavors

PART III: Genetic Information and Prenatal Diagnostics

CHAPTER 10: Genetic Information and Prenatal Testing

Genetic information
Prenatal testing
Sequence-based cell-free DNA testing
Fetal cell isolation

CHAPTER 11: GenePeeks

Company background
Patented technology
How does the process work?
Validation
Accuracy and sensitivity
Areas of improvement
Competitive advantage
Future applications
Interview with Anne Morriss
Company background
Patented technology
Competitive advantage
Areas of improvement and future outlook

CHAPTER 12: Verinata Health

Company background
The verifi® prenatal test
Clinical validation and reimbursement
Customer feedback

CHAPTER 13: Testing Specifications

PART IV: Survey Demographics

CHAPTER 14: Survey Results

Survey demographics
Areas of study
Rising technologies
Challenges encountered

PART V: Company Directory

References
Note: Product cover images may vary from those shown
Adroll
adroll